Back to home
Health·

Sant Julià de Lòria Microbiome and Cancer Immunotherapy Conference Ends Successfully

Dr. Antoni Martínez praises high participation from young professionals and students, new content on precision oncology, and the value of in-person training for future medical advancements.

Key Points

  • Second Microbiome and Cancer Immunotherapy Conference in Sant Julià de Lòria ends successfully after 3.5 days.
  • Dr. Antoni Martínez praises high participation from young professionals and students from Spain.
  • New content introduced on precision oncology and microbiome-immune system interactions.
  • In-person training highlighted as superior for team-based medical advancements.

Sant Julià de Lòria concluded its second Microbiome and Cancer Immunotherapy Conference on Saturday with a positive assessment after three and a half days of intensive lectures and practical sessions.

Dr Antoni Martínez, head of pathology at Barcelona's Hospital Clínic and a lead speaker, described the event as a clear success in terms of reception and participation from both civilian and scientific audiences. "These sessions have been a success, both in welcome and involvement across civil and scientific spheres, and they surely form the basis for future editions," he stated.

Most participants were young professionals in medical roles and students, many arriving from various parts of Spain. Martínez emphasised the positive outcomes from their interactions, describing the experience as enriching scientifically and personally. This edition expanded on the first with new content on precision oncology and algorithms for interpreting genetic data from the microbiome and its interaction with the immune system. "This year marked a successful consolidation of a highly specialised scientific programme," he noted.

The diverse participant base from Spain should help raise the initiative's profile, Martínez added. He expects attendees who enjoyed Andorra's scientific, cultural, and gastronomic offerings to act as ambassadors for coming years, with hopes that next year's event will be equally or more compelling.

Martínez outlined three main takeaways: the field remains an emerging area of medicine with much to learn; significant progress has already been made despite ongoing gaps; and in-person training offers greater value than virtual formats, particularly for team-based work. He pointed to afternoon sessions the previous day, where groups planned future hospital units for microbiome-based oncology immunology and brainstormed clinical trials in advanced areas.

The conference reinforces Sant Julià de Lòria's emergence as a centre for cutting-edge medical training, laying groundwork for expanded future gatherings.

Share the article via